The Cure from CRISPR Classroom

A weekly newsletter by Dr. Kris that demystifies complex medical technologies & connects you with relevant clinical trials based on your requests.

Connect

New Gene Therapy for Duchenne’s Approved

Plus: Myasthenia Gravis: New Drug Approved

Kris Tatiossian, PhD5 months ago

First Drug Ever for Friedrich’s Ataxia Approved

Plus: Promising New Treatment for Hidradenitis Suppurativa

Kris Tatiossian, PhD5 months ago

Hidradenitis Suppurativa

sickle cell disease

Friedreichs Ataxia

Polycythemia Vera

CRISPR Clinical Trials Ramp Up

Plus: Brain Cancer Breakthrough

Kris Tatiossian, PhD6 months ago

Breast Cancer and BRCA1

Plus: Hashimoto’s: From Tobacco to Treatment

Kris Tatiossian, PhD6 months ago

ankylosing spondylitis

Paraplegic man walks again with brain-spine bridge

Plus: Atrial Fibrillation, Blood Clots, and Factor XI

Kris Tatiossian, PhD6 months ago

wegeners granulomatosis

atrial fibrillation

paraplegia

Targeted Radiation to Fight Prostate Cancer

Plus: Slowing Parkinson's Progression

Kris Tatiossian, PhD6 months ago

Postural orthostatic tachycardia syndrome (POTS)

New Antibody Therapy for Head & Neck Cancer

Plus: RNA Combats Polycystic Kidney Disease

Kris Tatiossian, PhD7 months ago

polycystic kidney disease

Aerosolized Gene Therapy for Cystic Fibrosis

Plus: Natural Killer Cells Target Lung Cancer

Kris Tatiossian, PhD7 months ago

non alcoholic steatotic hepatitis (NASH)

Targeted Cell Therapy for Pancreatic Cancer

Plus: Immunotherapy Delivers Promising Results for Thyroid Eye Disease

Kris Tatiossian, PhD7 months ago

thyroid eye disease

cancer

x-linked alport syndrome

pancreatic cancer

nemaline myopathy

First Gene Therapy Applied Topically Delivers Results for DEB

Plus: Innovative Stargardt Gene Therapy Emerges

Kris Tatiossian, PhD7 months ago

dystrophic epidermolysis bullosa

dercums disease

stargardt disease

anti-aging

Myotic Dystrophy Treatment Breakthrough

PLUS: Mysteries Surround Ehlers-Danlos Syndrome

Kris Tatiossian, PhD7 months ago

leber congenital amaurosis

blindness

First CRISPR Treatment Poised for Historic Approval

PLUS: Complexity Challenges Progress in Autism

Kris Tatiossian, PhD8 months ago

sickle cell disease

beta thalassemia

autism

tuberous sclerosis complex

Preventing AML Relapse with Cell Engineering

PLUS: First Patient Dosed in Parkinson’s Stem Cell Trial

Kris Tatiossian, PhD8 months ago

cancer

duchenne muscular dystrophy

primary sclerosing cholangitis

leukemia

parkinsons

Multiple Sclerosis: Challenges & Opportunities

PLUS: CAR T Therapy Sends Lupus into Remission

Kris Tatiossian, PhD8 months ago

multiple sclerosis

type 1 diabetes

lupus

FDA Approves First Gene Therapy for Bladder Cancer

PLUS: New Trial for Hereditary Angioedema

Kris Tatiossian, PhD8 months ago

retinitis pigmentosa

hereditary angioedema

Open Enrollment for HIV Clinical Trial

PLUS: New Trial for Type 1 Diabetes Announced

Kris Tatiossian, PhD9 months ago

huntington's disease

familiar hypercholesterolemia

type 1 diabetes

hiv

viral infections